mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
-0.19 |
0.2 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.2 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.2 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |